DENTSPLY SIRONA (NASDAQ:XRAY) Price Target Cut to $20.00 by Analysts at Barrington Research

DENTSPLY SIRONA (NASDAQ:XRAY) had its price objective lowered by Barrington Research from $24.00 to $20.00 in a research report released on Friday morning,Benzinga reports. Barrington Research currently has an outperform rating on the medical instruments supplier’s stock. Barrington Research also issued estimates for DENTSPLY SIRONA’s Q1 2025 earnings at $0.28 EPS, Q4 2025 earnings at $0.55 EPS, FY2025 earnings at $1.86 EPS, Q1 2026 earnings at $0.37 EPS, Q2 2026 earnings at $0.53 EPS, Q3 2026 earnings at $0.57 EPS, Q4 2026 earnings at $0.59 EPS, FY2026 earnings at $2.05 EPS and FY2027 earnings at $2.30 EPS.

A number of other equities analysts have also issued reports on XRAY. Morgan Stanley decreased their target price on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating for the company in a research report on Tuesday, December 17th. Jefferies Financial Group lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and decreased their target price for the company from $30.00 to $20.00 in a research report on Thursday, January 23rd. Robert W. Baird decreased their target price on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a research report on Friday. UBS Group decreased their target price on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research report on Tuesday, December 3rd. Finally, Wells Fargo & Company assumed coverage on shares of DENTSPLY SIRONA in a research report on Friday, February 14th. They issued an “equal weight” rating and a $20.00 target price for the company. Eleven research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $23.58.

DENTSPLY SIRONA Stock Down 3.5 %

XRAY stock opened at $16.55 on Friday. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA has a fifty-two week low of $16.21 and a fifty-two week high of $34.91. The firm’s 50-day simple moving average is $18.88 and its 200 day simple moving average is $21.55. The stock has a market cap of $3.29 billion, a PE ratio of -8.00, a price-to-earnings-growth ratio of 1.80 and a beta of 0.96.

DENTSPLY SIRONA Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 28th will be issued a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 3.87%. The ex-dividend date is Friday, March 28th. DENTSPLY SIRONA’s payout ratio is -30.92%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in XRAY. Pacer Advisors Inc. boosted its holdings in shares of DENTSPLY SIRONA by 15,105.1% in the fourth quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier’s stock worth $85,478,000 after buying an additional 4,473,972 shares during the period. Nuance Investments LLC boosted its holdings in shares of DENTSPLY SIRONA by 25.0% in the fourth quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier’s stock worth $257,103,000 after buying an additional 2,708,097 shares during the period. Norges Bank acquired a new position in shares of DENTSPLY SIRONA in the fourth quarter worth about $45,730,000. AQR Capital Management LLC boosted its holdings in shares of DENTSPLY SIRONA by 245.1% in the fourth quarter. AQR Capital Management LLC now owns 2,893,023 shares of the medical instruments supplier’s stock worth $54,389,000 after buying an additional 2,054,767 shares during the period. Finally, Price T Rowe Associates Inc. MD boosted its holdings in shares of DENTSPLY SIRONA by 18.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier’s stock worth $238,186,000 after buying an additional 1,975,404 shares during the period. 95.70% of the stock is currently owned by institutional investors and hedge funds.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.